nope, you argued that ropren would never be given approval by the RMOH and would demand an expensive phase 3 clinical trial. a manufacturing license is a completely different issue. dont worry tharlow, i dont think anyone here expected you to live up to you word. you have zero credibility. back on igniore for you.
- Forums
- ASX - By Stock
- SLA
- heading lower on profit taking
heading lower on profit taking, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online